Post-Surgery Atezolizumab Fails to Provide Benefit in Combination With Chemotherapy for TNBC

Adjuvant atezolizumab did not provide a clinical benefit when added to chemotherapy in patients with triple-negative breast cancer.

Related Keywords

Italy ,Milan ,Lombardia ,San Antonio ,Texas ,United States ,Heather Mcarthur ,Clinical Breast Cancer Research ,Ut Southwestern Medical Center ,European Breast Cancer Conference ,Komen Distinguished Chair ,Medical Center ,Antonio Breast Cancer Symposium ,Alexandra Impassion030 Trial ,Nct03498716 ,14th European Breast Cancer Conference ,Atezolizumab ,Atezolizumab Plus Chemotherapy ,Triple Negative Breast Cancer ,Ntnbc ,